Fierce Pharma
OCTOBER 23, 2024
With an expanded recommendation from the Center for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices (ACIP), pneumococcal conjugate vaccines (PCV) from Pfizer and | The CDC's immunization committee voted to expand the recommendation for pneumococcal conjugate vaccines, including both Pfizer’s Prevnar 20 and Merck’s newer Capvaxive.
MedCity News
OCTOBER 23, 2024
FarmboxRx CEO Ashley Tyrner explains why she never accepted outside capital after launching her company that serves nutritional needs of Medicaid and Medicare members. The post Video: Why This Startup CEO Never Accepted Outside Capital appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
OCTOBER 23, 2024
The war is on between compounding pharmacies making knockoff versions of popular weight loss drugs and pharma giants Novo Nordisk and Eli Lilly, who want to protect their right to sell their patent | Novo Nordisk has asked the FDA to prevent compounders from manufacturing copycat versions of its juggernaut diabetes and obesity treatments Ozempic and Wegovy, claiming the drugs are too complex to safely replicate.
MedCity News
OCTOBER 23, 2024
For patients who may be unable to afford the high cost of GLP-1 obesity drugs or are worried about the side effects, it’s important for healthcare providers to offer education on herbal alternatives and consider these as part of the broader treatment conversation. The post Can Herbal Alternatives Ease the Economic Burden of Weight Loss Drugs? appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Pharma
OCTOBER 23, 2024
By squeezing Regeneron’s Eylea, eye disease drug Vabysmo has become one of the biggest growth drivers for Roche. | Despite the potential imminent launch of a biosimilar to Regeneron's Eylea, Roche expects the market potential will remain stable for Vabysmo. Meanwhile, Sarepta-partnered Elevidys delivered a big surprise in the third quarter.
pharmaphorum
OCTOBER 23, 2024
Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by these manufacturers.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
OCTOBER 23, 2024
An Alto drug candidate for major depressive disorder failed to meet primary and secondary goals of a placebo-controlled Phase 2b test. The disappointing result could stymie plans for further tests of the small molecule in PTSD and bipolar depression. The post Alto Neuroscience’s Depression Trial Failure Sends Shares Into Downward Spiral appeared first on MedCity News.
Fierce Pharma
OCTOBER 23, 2024
While Regeneron may have lost its latest bid to block the launch of Amgen’s Eylea biosimilar Pavblu, the New York-based pharma isn’t throwing in the towel just yet. | Amgen is preparing to launch its Eylea biosimilar, Pavblu, after another victory over Regeneron in court. That said, Regeneron is appealing the decision and stressed that it continues to believe Amgen's copycat infringes multiple Eylea patents.
MedCity News
OCTOBER 23, 2024
To protect healthcare organizations and minimize the risk of breaches, software development companies must stay vigilant regarding the biggest vulnerability of any digital system: the users. Here are some ways to minimize irresponsible digital behavior and some tools to enhance the security of medical digital systems. The post Zero Trust: Mitigating Cybersecurity Risks in Digital Medical Ecosystems appeared first on MedCity News.
Fierce Pharma
OCTOBER 23, 2024
With expanded FDA nod for RSV shot Abrysvo, Pfizer gains edge on GSK's Arexvy. But will it amount to much?
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
MedCity News
OCTOBER 23, 2024
Join us Thursday, October 24, at 1pm ET for a webinar sponsored by Personify Health on how employers navigate the intricate challenges posed by rising healthcare costs while prioritizing employee health and well-being. The post How Do Employers Address Rising Healthcare Costs? appeared first on MedCity News.
Fierce Pharma
OCTOBER 23, 2024
Eli Lilly’s Alzheimer’s disease offering Kinsunla is poised to face a tough road ahead in the U.K. | Lilly's Alzheimer treatment fell to the same fate as Biogen and Eisai's rival Leqembi in the U.K., with the region's cost watchdog declining to support reimbursement through its National Health Service.
Referral MD
OCTOBER 23, 2024
Prior authorization is a crucial healthcare topic related to the relationship between a patient, their healthcare provider, and the insurance company. This blog will outline everything you need to know about prior authorization , its definition, and its importance to healthcare. What is prior authorization? A patient’s physician or healthcare provider can decide what treatment the patient needs.
MedCity News
OCTOBER 23, 2024
Here are nine notable announcements shared at the HLTH conference held this week in Las Vegas. The post 9 HLTH Announcements You Don’t Want to Miss appeared first on MedCity News.
PharmaTech
OCTOBER 23, 2024
This article presents an overview of FDA’s recent update to the guidance document, Control of Nitrosamine Impurities in Human Drugs.
MedCity News
OCTOBER 23, 2024
During a speech at HLTH 2024, Jill Biden announced that 23 recipients have been chosen for ARPA-H’s Sprint for Women’s Health. The recipients address issues like cancer, ovarian health and gynecological care. The post ARPA-H Awards $110M to 23 Startups and Innovators In Women’s Health, Jill Biden Announces appeared first on MedCity News.
pharmaphorum
OCTOBER 23, 2024
US lawmakers fear Pfizer and Lilly's recent forays into direct-to-consumer distribution of medicines via telehealth could violate anti-kickback laws.
Pharmaceutical Technology
OCTOBER 23, 2024
A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
PharmaVoice
OCTOBER 23, 2024
As Sanofi prepares to halt production on its dengue vaccine in 2026, locally acquired infections in the U.S. are raising the alarm.
pharmaphorum
OCTOBER 23, 2024
A new FDA approval has given Pfizer a broader label for its respiratory syncytial virus (RSV) vaccine Abrysvo than rival shots from GSK and Moderna, but it may not make much of a difference in the battle for market share.The US regulator has cleared Abrysvo for use in adults aged 18 to 59 at risk of RSV-related disease, extending its earlier label which covered the 60 and over age bracket.
MedCity News
OCTOBER 23, 2024
A panel of experts at the HLTH conference agreed that states with strict abortion measures are likely to see negative economic impact as medical residents decline to go to them for training and physicians move out. The post Strict Abortion Laws Are Likely Already Having An Economic Impact appeared first on MedCity News.
Pharmaceutical Technology
OCTOBER 23, 2024
Darzalex will now be available to patients with newly diagnosed multiple myeloma eligible for autologous stem cell transplant.
MedCity News
OCTOBER 23, 2024
In a series of articles to promote INVEST 2025 in Chicago April 29-30, we are highlighting investment insights and perspectives in the runup to the boutique event for traditional and strategic healthcare investors and startups. Register today! The post Springboard Enterprises Executive-in-Residence Shares Advice to Startups appeared first on MedCity News.
pharmaphorum
OCTOBER 23, 2024
On Sunday, the clocks in the UK will be set back by an hour as British Summer Time ends, and some believe the practice of twice-yearly changes could impact our health.Many will celebrate having an extra hour in bed – perhaps forgetting how they lost an hour at the end of March when the clocks went forward – but the British Sleep Society (BSS) is advocating for the changes to be abolished altogether and for the UK to return to Standard or Greenwich Mean Time (GMT).
PharmaTimes
OCTOBER 23, 2024
New treatment option for patients with newly diagnosed multiple myeloma
pharmaphorum
OCTOBER 23, 2024
Eli Lilly's Alzheimer's therapy Kisunla has been approved in the UK, but is too expensive to be funded by the NHS, according to NICE.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharma Marketing Network
OCTOBER 23, 2024
Building a strong network in the pharmaceutical industry is no longer optional—it’s essential. LinkedIn, the world’s largest professional networking platform, offers an incredible opportunity for pharma professionals to connect, collaborate, and grow their careers. Whether you’re looking to promote a new drug brand or stay updated on trending healthcare innovations , having a broad network is key.
Evolve Your Success
OCTOBER 23, 2024
Join us as we welcome Justin Ramsaran, the dynamic VP of Digital Health at Fukuda Denshi America and CEO of R Group, who is shaping the future of healthcare with his expertise in remote patient monitoring and cardiac care innovation. Justin shares his unique journey of balancing leadership roles in two innovative companies and delves into the rich history of Fukuda Denshi, a pioneer in ECG technology since 1938.
Pharma Marketing Network
OCTOBER 23, 2024
In today’s rapidly evolving pharmaceutical industry, staying ahead isn’t just a matter of developing the next breakthrough drug. It’s about knowing what the market wants, understanding your competition, and predicting the next trend before it happens. That’s where pharma market research comes in. Whether you’re launching a new drug or competing with established brands like Humira or Jardiance , market research provides the insights you need to succeed.
PharmExec
OCTOBER 23, 2024
Peter Marks, director, Center for Biologics Evaluation and Research, FDA, presented the keynote presentation on the future of gene therapy as part of the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
266 
Let's personalize your content